A new stem cell therapy has repaired blinding damage to the cornea in 93% of patients in an early clinical trial. The cornea ...

The cornea is the transparent frontmost layer of the eye that both protects it and helps us see clearly by focusing light on ...

An experimental stem cell therapy reversed corneal damage in half of the participants from a recent clinical trial.

Stem cells from the patient's healthy eye transplanted into the injured eye successfully repairing previously "irreversible" ...

Sight-robbing injuries to the cornea can be repaired using a groundbreaking experimental stem cell treatment, a new study ...

Results from a phase 1/2 clinical trial of a novel stem cell treatment for cornea injuries found 14 patients treated and tracked for 18 months had a more than 90% success rate at restoring the ...

The study also suggests that earlier treatment might lead to better results. Some of the participants' eye injuries occurred many years ago, and their injured corneas had more extensive scarring ...

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the ...

This probably explains why one patient, who had an extensive eye injury, didn't fully benefit from the treatment after 18 months, she theorized. The new therapy can only treat patients who are ...